Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COUNTERFEIT ZANTAC SEIZURE INVOLVES 1,454 BOTTLES

Executive Summary

COUNTERFEIT ZANTAC SEIZURE INVOLVES 1,454 BOTTLES labeled as Glaxo's "Zantac 150." Each bottle contains 60 tabs. Following the filing of an April 12 complaint by Glaxo alleging that certain Zantac 150 tablets were counterfeit and liable to seizure, a U.S. marshall retrieved the bottles from FDA's New York district office. According to the complaint, which was filed in Brooklyn Federal Court, FDA originally seized the product, on July 21, from World Medical and Surgical Supply Corp. of Flushing, New York, and from E.M. Sales, Inc. of Farmingdale, New York. Glaxo's manager of package engineering Bruce Cohen examined the inner seals of the bottles and determined that the product had not been packaged by Glaxo. Cohen's examination, the complaint says, "revealed that said seals differed from authentic Glaxo seals with respect to the adhesion method utilized and with respect to typeface and style of the imprinted 'Glaxo' tradename logo." Therefore, Cohen found that the seals "were not authentic 'Glaxo' seals and that defendent article of drug was not packaged or distributed by Glaxo." Since Glaxo "did not authorize the use" of its name for the product, it is "a counterfeit drug" under the FD&C Act, the complaint states. World Medical had initiated a recall of various drugs including Zantac in late July because of "lack of assurance of product origin and authenticity" ("The Pink Sheet" Aug. 28, 1989, T&G-16). World Medical, which conducts business as Elm Drugs and First Providers, said that it purchased the drugs from a drug store that was going out of business.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017448

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel